Endeavour Vision Overview
Endeavour Vision is a private equity firm focused on supporting growth-stage medtech and digital health companies. The firm invests in medical innovations that provide superior clinical benefits for patients or bring significant efficiencies to health systems. With offices in Geneva, Switzerland, and Minneapolis, U.S., Endeavour Vision offers strategic and operational expertise, extensive international experience, and a proven track record of successful exits, including investments in Relievant Medsystems, Vertiflex, and Symetis.
Is Endeavour Vision the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Endeavour Vision, along with a list of other relevant VCs, is available on Hopohopo.io.
Endeavour Vision
Investment focus
Product type
- Software
- Hardware
- Drugs / Pharma
Industries / verticals
- Digital & Consumer health
- MedTech & Devices
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
US$1,000,000 - US$5,000,000
Contact information
President & Managing Partner
Damien Tappy
Senior Investment Director
Fernando Pacheco
Managing Partner
Bernard Vogel
Partner
Alexander Schmitz
Investment Director
Toby AuWerter
How to approach funds like Endeavour Vision
When approaching Endeavour Vision, founders should highlight how their technology addresses unmet clinical needs and demonstrates clear, quantifiable outcomes for patients or health systems. Emphasize robust clinical validation, regulatory progress, and a scalable commercialization strategy, as the team values evidence-backed solutions with global market potential. Articulate how your leadership team’s experience aligns with navigating complex healthcare environments and driving adoption in both established and emerging markets.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
